What to Expect From Rite Aid Earnings
Rite Aid is scheduled to report its fiscal third-quarter financial results before the markets open on Thursday.
All Work
Chris Lange
Is Global Payments Paying Too Much for Heartland?
Global Payments has announced that it has entered into a definitive agreement to acquire Heartland Payment for $100 per share, or approximately $4.3 billion.
SEC Issues Fraud Charges Over Native American Bonds
Atlantic Asset Management stands accused of investing clients in certain bonds with a hidden financial benefit to a broker-dealer connected to the firm.
Bats Global Markets Files for IPO
Bats Global Markets has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
CyberArk Beats Out Peers for Homeland Security Award
CyberArk Software announced that it was named a winner in the 2015 GSN Homeland Security Awards in two categories.
Advaxis Skyrockets on Resumed Clinical Trials
Advaxis has announced that the FDA has lifted the clinical hold on all of its Investigational New Drug (IND) applications for its three product candidates
Array BioPharma Rallies on Late-Stage Win
Array BioPharma reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial.
Lakeland Stumbles on Mixed Earnings
Lakeland Industries reported mixed fiscal 2016 third-quarter financial results after the markets closed on Tuesday.
Are Inland Real Estate Shareholders Getting Enough in the Merger?
Inland Real Estate has announced that it entered into a definitive agreement to be acquired by real estate funds managed by DRA Advisors.
Pacira Pharma Soars on Settled FDA Case
Pacira Pharmaceuticals announced that it achieved an amicable resolution with the FDA for a lawsuit filed earlier this year that effectively lifts the restriction on its Exparel.
Why Neothetics Is Getting Destroyed
Neothetics Inc. (NASDAQ: NEOT) was absolutely crashed in Tuesday’s session after announcing top-line results from a late stage trial that fell short.
What to Expect From Oracle Earnings
Oracle is scheduled to report its fiscal second-quarter financial results after the markets close on Wednesday.
Spark Therapeutics Files for Secondary Offering
Spark Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for a secondary offering.
Should Anyone Be Surprised by 3M’s Lower Guidance?
Reflecting the realities of a continued slow-growth global economy, 3M expects 2015 full-year organic growth to be lower than previous guidance.
Short Sellers Back Off Lumber Liquidators
This year has not a good one for Lumber Liquidators, but its shares traded up sharply Tuesday morning.
FuelCell Falls Short on the Bottom Line
FuelCell Energy reported its fiscal fourth-quarter financial results after the markets closed on Monday.
What to Expect From FedEx Earnings
FedEx is scheduled to report its fiscal second-quarter financial results after the markets close on Wednesday.
AcelRx Tanks on Pre-NDA Results
AcelRx intends to pursue an ARX-04 indication for moderate-to-severe pain in a medically supervised setting. However, this might be farther out than investors anticipated.
SEC Freezes Assets in Penny Stock Sports Scam
The SEC has announced fraud charges and a court-ordered asset freeze obtained against a Florida-based penny stock company.
Newell Rubbermaid Moves to Acquire Jarden
Newell Rubbermaid and Jarden announced that they have entered into a definitive agreement to combine, but investors don’t seem overly thrilled.